Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 5/20 | 0.60 |
| ▸ | PRKCG | P05129 | 5/20 | 0.60 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.60 |
| ▸ | PRKCB | P05771 | 4/20 | 0.60 |
| ▸ | PRKCH | P24723 | 4/20 | 0.60 |
| ▸ | PRKCI | P41743 | 4/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 4/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 4/20 | 0.60 |
| ▸ | PRKCZ | Q05513 | 4/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 4/20 | 0.60 |
| ▸ | PRKD1 | Q15139 | 4/20 | 0.60 |
| ▸ | USP2 | O75604 | 2/20 | 0.60 |
| ▸ | TP53 | P04637 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phorbol SCHEMBL7615331 | 0.94 | PRKCA (0.62) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL27419386 | 0.94 | PRKCA (0.62) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL28866474 | 0.94 | PRKCA (0.62) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL64353 | 0.94 | PRKCA (0.62) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL22973790 | 0.94 | PRKCA (0.62) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL27299282 | 0.93 | PRKCA (0.63) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL27333666 | 0.91 | PRKCA (0.62) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL27579226 | 0.89 | PRKCA (0.67) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL7566989 | 0.89 | PRKCA (0.60) | PRKCAPRKCGPRKD3PRKCBPRKCH | |
| Phorbol SCHEMBL28306320 | 0.89 | PRKCA (0.63) | PRKCAPRKCGPRKD3PRKCBPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113686830-B | Batch semi-channel function level detection method based on fluorescent dye uptake | 中国环境科学研究院 | 2022-05-20 | — | — | CN | claimed |
| CN-113686830-A | Batch semi-channel function level detection method based on fluorescent dye uptake | 中国环境科学研究院 | 2021-11-23 | — | — | CN | claimed |
| CN-119997962-A | Improving efficacy and sustained response of immunotherapy | 凯德药业股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119343444-A | Method for preparing lymphocytes for cell therapy | 凯德药业股份有限公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-116997564-A | Improving immune cell function | 凯德药业股份有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-116113689-A | Improving immune cell function | 凯德药业股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-115485293-A | Chimeric antigen receptor for HER2 and methods of use thereof | 埃克苏马生物技术公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-114796474-A | Vaccine compositions with improved stability and immunogenicity | 诺瓦瓦克斯股份有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114786697-A | Diterpenoids acting on Protein Kinase C (PKC) | K-GEN股份有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114699519-A | Vaccine compositions with improved stability and immunogenicity | 诺瓦瓦克斯股份有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-114667285-A | Antiviral pyrazolopyridinone compounds | 诺华股份有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-101039689-B | Topical compositions and methods for epithelial-related disorders | SIGNUM BIOSCIENCES INC | 2013-01-30 | — | — | CN | disclosed |
| CN-101641080-A | Use of chroman-4-one derivatives | MERCK PATENT GMBH DE | 2010-02-03 | — | — | CN | disclosed |
| CN-101277614-A | Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway | ACCELALOX INC (US) | 2008-10-01 | — | — | CN | disclosed |
| CN-101039689-A | Topical compositions and methods for epithelial-related disorders | SIGNUM BIOSCIENCES INC (US) | 2007-09-19 | — | — | CN | disclosed |
| CN-1980687-A | Albumin fusion proteins | HUMAN GENOME SCIENCES INC (US) | 2007-06-13 | — | — | CN | disclosed |
| CN-1210029-C | Treating for skin disease | BTG INT LTD (GB) | 2005-07-13 | — | — | CN | disclosed |
| CN-1158073-C | Application of protein kinase C inhibitor in preparation of medicine | — | 2004-07-21 | — | — | CN | disclosed |
| CN-1330545-A | Treating for skin disease | BTG INT LTD (GB) | 2002-01-09 | — | — | CN | disclosed |
| CN-1222850-A | Therapeutic treatment for VEGF related occular diseases | LILLY CO ELI (US) | 1999-07-14 | — | — | CN | disclosed |